Long term haemodynamic, pulmonary function and symptomatic effects of pirbuterol in COPD-Reference-Cited by-同舟云学术

Long term haemodynamic, pulmonary function and symptomatic effects of pirbuterol in COPD

Published:1989-01 Issue:1 Volume:83 Page:59-65
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Neilly J.B.,Carter R.,Tweddel A.,Martin W.,Hutton I.,Banham S.W.,Stevenson R.D.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference30 articles.

1. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease;Weitzenblum;Thorax,1981

2. Prognosis in severe chronic obstructive pulmonary disease;Kok-Jensen;Scand J Respir Dis,1974

3. Haemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale;Rubin;Am J Cardiol,1981

4. Effects of hydralazine on haemodynamics, ventilation and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension;Keller;Am Rev Respir Dis,1984

5. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine;Simonneau;N Engl J Med,1981

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the efficacy and tolerability of mepifylline oral solution versus inhaled ipratropium bromide in patients with stable chronic obstructive pulmonary disease: A randomized, active-controlled, open-label study;Current Therapeutic Research;2002-02

2. Haemodynamic effects of atrial natriuretic peptide in hypoxic chronic obstructive pulmonary disease.;Thorax;1994-03-01

3. Pharmacologic Treatment of Primary and Secondary Pulmonary Hypertension;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;1991-03-04